| Oct 11 |
Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress
|
| Oct 9 |
Capricor Therapeutics Inc (CAPR) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Oct 9 |
Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
|
| Oct 8 |
Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?
|
| Oct 4 |
Capricor stock rallies 20% on DMD data presentation update
|
| Oct 4 |
Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
|
| Oct 3 |
Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?
|
| Oct 1 |
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
|
| Sep 29 |
Wall Street Breakfast: The Week Ahead
|
| Sep 26 |
High Growth Tech Stocks To Watch In September 2024
|
